Impact of serum C-reactive protein level on the prognosis of patients with hepatocellular carcinoma undergoing TACE
Chung Hwan Jun, Ho Seok Ki, Ki Hoon Lee, Kang Jin Park, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, Hyun Soo Kim, Sung Kyu Choi, Jong Sun Rew
Clin Mol Hepatol. 2013;19(1):70-77.   Published online 2013 Mar 25     DOI: https://doi.org/10.3350/cmh.2013.19.1.70
Citations to this article as recorded by Crossref logo
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park
Cancers.2019; 11(4): 509.     CrossRef
Is there an association between CRP levels and tumor size in breast cancer patients?
Emine Petekkaya, Ibrahim Petekkaya, Erdinc Nayır, Kadrid Altundağ
Journal of Oncological Sciences.2018; 4(2): 106.     CrossRef
Validation of the Risk Prediction Models STATE-Score and START-Strategy to Guide TACE Treatment in Patients with Hepatocellular Carcinoma
Aline Mähringer-Kunz, Roman Kloeckner, Michael B. Pitton, Christoph Düber, Irene Schmidtmann, Peter R. Galle, Sandra Koch, Arndt Weinmann
CardioVascular and Interventional Radiology.2017; 40(7): 1017.     CrossRef
Prognostic value of the combination of serum levels of vascular endothelial growth factor, C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization
Zhi-Dong Xuan, Li Zhou, Yu Wang, Xue Zheng
Expert Review of Anticancer Therapy.2017; 17(12): 1169.     CrossRef
Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma
Arno Kornberg, Ulrike Witt, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum
Biomarkers.2016; 21(2): 152.     CrossRef
The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization
Samia Rekik, Erwan Guyot, Mohannad Bhais, Yves Ajavon, Véronique Grando, Valérie Bourcier, Gisèle Nkontchou, Pierre Nahon, Nicolas Sellier, Olivier Seror, Nathalie Ganne-Carrie, Jean-Charles Nault
Digestive and Liver Disease.2016; 48(9): 1088.     CrossRef
Use of18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
Min Jin Kim, Young Seok Kim, Youn Hee Cho, Hee Yoon Jang, Jeong-Yeop Song, Sae Hwan Lee, Soung Won Jeong, Sang Gyune Kim, Jae Young Jang, Hong Su Kim, Boo Sung Kim, Won Hyung Lee, Jung Mi Park, Jae Myung Lee, Min Hee Lee, Deuk Lin Choi
The Korean Journal of Internal Medicine.2015; 30(3): 308.     CrossRef
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors
Jeong-Yeop Song, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Soo Ji Jin, Jung Mi Park, Gyu Seong Choi, Jun Chul Chung, Min Hee Lee, Youn Hee Cho, Moon Han Choi, Dong Choon Kim, Hyun Jong Choi, Jong Ho Moon, Se Hwan Lee, Seung Won Jeong, Jae Young Jang, H
Nuclear Medicine Communications.2015; 36(4): 319.     CrossRef
Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
A. Kornberg
ISRN Hepatology.2014; 2014: 1.     CrossRef